Measuring hypoxia in tumors is crucial for understanding its role in cancer progression and for tailoring treatment strategies. Techniques to assess tumor hypoxia include imaging techniques like positron emission tomography (PET) and magnetic resonance imaging (MRI) using hypoxia-specific tracers. Additionally, the expression levels of hypoxia-related biomarkers can be evaluated through biopsy samples, providing insights into the degree of hypoxia within the tumor tissue.
